In this guide
What is glutathione?
Glutathione is a small molecule made from three amino acids (glutamate, cysteine and glycine) that nearly every cell in the body makes for itself. People take it as capsules, injections and IV drips, mostly for lighter skin, the liver and general wellness, and it is a licensed medicine in Japan and Italy. [1], [2], [3], [4]
Inside cells it works as an antioxidant: the active, “reduced” form (GSH) hands electrons to harmful reactive molecules and becomes the “oxidized” form (GSSG), which enzymes then recycle back. It also helps cells attach and clear some drugs and chemicals. The liver is a major source. [1], [5], [6]
Chemically it is a tripeptide, a chain of three amino acids, but it is not a signaling peptide or a hormone. An unusual bond protects it from ordinary protein-digesting enzymes; a separate enzyme, gamma-glutamyl transferase (GGT), breaks it down outside cells. [1], [5]
Its status depends on the product. Japan licenses glutathione tablets (sold since 1968) and an injection (the current product has been sold since 2000), and Italy licenses an injection to prevent nerve damage from cisplatin chemotherapy. In the United States it is sold as a dietary supplement ingredient; injections come from compounding pharmacies and are not FDA-approved. [3], [7], [4], [8], [9], [10]

| At a glance | |
|---|---|
| Building blocks | Glutamate, cysteine and glycine [1] |
| Formula and mass | C10H17N3O6S · 307.32 g/mol [2], [3] |
| Forms you will see | Reduced glutathione (GSH), oxidized glutathione (GSSG), glutathione sodium (injection salt) and S-acetyl glutathione, which is a different molecule [6], [11], [12] |
| Licensed medicine in | Japan (tablets and injection), Italy (injection for chemotherapy), the Philippines (injection with cisplatin only) [3], [4], [13] |
| Not the same as | N-acetylcysteine (NAC) or glycine, which the body uses to make its own glutathione [14] |
Typical Glutathione Protocols
| Labeled product and use | Amount each time | Frequency | Total per day | Course |
|---|---|---|---|---|
| Japan, injection: poisoning, cyclic vomiting, chronic liver disease, eczema, hives and dermatitis, melasma and other pigmentation, severe pregnancy sickness and high blood pressure in pregnancy, corneal injury, radiation side effects | 100–200 mg, intramuscular (into a muscle) or intravenous (into a vein) | Once daily | 100–200 mg | Not fixed; adjusted for age and symptoms |
| Japan, tablets: poisoning (including metals), cyclic vomiting, severe pregnancy sickness and high blood pressure in pregnancy | 50–100 mg, oral (swallowed) | 1–3 times a day | 50–300 mg | Not fixed; adjusted for age and symptoms |
| Italy, injection: preventing nerve damage from cisplatin chemotherapy | 1.5 g per square metre of body surface (about 2,500 mg), slow IV | Once, 15–30 minutes before chemotherapy | About 2,500 mg on chemotherapy days | Follows the chemotherapy; for long treatment, 600 mg into a muscle or slow IV (frequency not stated) |
On the Japanese label, the injection is 100–200 mg once a day into a muscle or a vein and the tablets are 50–100 mg one to three times a day; neither sets a fixed course. The Italian dose is for people receiving platinum chemotherapy and is not a wellness dose. [3], [7], [4]
What amounts did oral studies use?
Outside Japan, oral glutathione is sold mainly as a supplement. These rows are complete schedules from randomized trials.
| Example | Amount each time | Frequency | Total per day | Duration |
|---|---|---|---|---|
| Low | 125 mg | Twice daily | 250 mg | 6 months Healthy adults; raised glutathione in blood and red cells |
| Mid | 250 mg | Twice daily | 500 mg | 4 weeks Skin-lightening trial |
| High | 500 mg | Twice daily | 1,000 mg | 6 months Healthy adults; larger rises in blood, plasma and immune cells |
The most common oral pattern, in trials and on dosing pages alike, is 250–1,000 mg a day, taken once or split into two doses; the trials lasted 4 weeks to 6 months. [15], [17], [18], [19], [20]
What schedules are used for glutathione injections?
Outside Japan and Italy, injections come from compounding pharmacies, clinics and “research” vendors. These rows are complete schedules published by a pharmacy and a clinic; no study has tested them.
| Example | Amount each time | Frequency | Weekly total | Duration |
|---|---|---|---|---|
| Low | 200 mg (1 mL) | Once or twice a week, into a muscle or subcutaneous | 200–400 mg | Not stated |
| Mid | 200 mg (1 mL) | Up to 3 times a week, into a muscle | Up to 600 mg | 4 weeks |
| High | 400 mg (2 mL) | Up to 3 times a week, into a muscle | Up to 1,200 mg | 4 weeks |
The most common injected pattern in the reviewed sources is 200 mg per injection, one to three times a week, into a muscle or subcutaneous, which adds up to 200–600 mg a week. [23], [21], [22], [24], [25] Community education groups most often describe 200 mg three times a week.
What doses are used for IV glutathione?
IV glutathione is given by clinics as a quick “push” from a syringe or as a slower drip. The study rows are the full schedules researchers used; the website row is one online dosing guide's general wellness schedule.
| Source | Amount each time | Frequency | Weekly total | Duration |
|---|---|---|---|---|
| Used in studies | ||||
| Parkinson's disease trial, 2009 | 1,400 mg over 10 minutes | 3 times a week | 4,200 mg | 4 weeks Not better than placebo |
| Skin-lightening study, 2016 | 1,200 mg, mixed with vitamin C and collagen | Twice a week | 2,400 mg | 6 weeks Not randomized; 8 of 25 people had abnormal liver tests |
| Website claims | ||||
| General wellness schedule | 600–1,200 mg | 1–2 times a week | 600–2,400 mg | 4–8 weeks |
- Titration Changing the amount in steps
- The labels and the oral trials use a fixed amount from the first day. [3], [15] Injection pages add steps: one describes 100 mg a day subcutaneous for two weeks, then 150 mg, then 200 mg a day in weeks 5–8; another starts at 200–600 mg once or twice a week, then moves to 600–1,200 mg a week split into two or three injections. [28], [29] Community education groups commonly describe 50 mg, then 100 mg, then 200 mg, about two weeks each.
- Breaks and cycles
- The labels and trials give no cycle. Injection pages describe 4–8-week courses, or 4–12 weeks followed by at least 4 weeks off. [30], [23], [31] Community education groups more often describe continuous use for months or years, with breaks taken for cost or tiredness of injecting. No study has compared taking breaks with not taking them.
Read the units: glutathione amounts are in milligrams (mg), about a thousand times larger than the microgram doses used for most peptides. A vial marked 600 mg or 1,500 mg holds that amount in total, not per mL. The Italian dose is set by body surface area. Oral and injected amounts are not interchangeable, and Health Canada's antioxidant monograph for licensed oral products lists a 743 mg daily maximum. [4], [32]
Low, mid and high are alternatives, not steps to move through, and only the label rows describe approved medicines.
Before any injection or IV dose: these schedules say nothing about product quality, and contaminated products are the best-documented harm. In 2026, FDA and the CDC linked fever, chills and signs of shock to compounded glutathione made with a supplement-grade ingredient and given IV, into a muscle or subcutaneous. Japan's licensed injection label also lists severe allergic reactions (anaphylaxis). CDC advises contacting a healthcare provider promptly about fever, chills or severe body aches after a dose, and seeking emergency care for difficulty breathing, fainting or signs of shock; these are not a “detox” reaction. There are no human safety studies in pregnancy, and inhaled glutathione narrowed the airways of people with mild asthma. [33], [34], [3], [4], [35] Read the full risks ↓
Where protocols differ: per injection or per week, muscle or skin, breaks and IV amounts ↓
Where these numbers come from
Label table. The Japanese rows come from the official package inserts for Tathion injection (revised September 2024) and Tathion tablets (revised July 2026), read in Japanese. The Italian row comes from the TAD prescribing information as published in a copy of a document AIFA released on 29 April 2021; AIFA's own database page could not be read. [3], [7], [4]
Oral table. The low and high rows are the two arms of a six-month randomized, placebo-controlled trial in 54 healthy adults; the mid row is a four-week randomized, placebo-controlled skin trial in 60 people. A separate four-week trial of 500 mg twice daily found no change in red-cell glutathione, so these doses are not guaranteed to raise levels. [15], [16], [36]
Injection table. The low row is a compounding pharmacy's suggested use; the mid and high rows are a clinic's four-week plan. We compared 35 dosing pages and grouped their numbers into 13 families. The 200 mg family (12 pages, usually 200 mg per mL vials) has no traceable research origin; the nearest official anchor is the Japanese label's 100–200 mg once daily. [21], [22], [3]
IV table. The study rows are the published schedules of a randomized Parkinson's trial and a non-randomized skin study; the website row is one online dosing guide's general wellness schedule. Across 19 pages, stated IV amounts ran from 500 to 3,000 mg per session, with a middle value of 1,200 mg among 18 single-number statements. That describes websites, not a safe or effective range. [26], [27], [23]
Left out. A calculator that pairs a 15 mg vial with a 600 mg dose, vial counts that do not cover the page's own schedule, nasal amounts doubled by quoting them “per nostril”, an IV skin trial that could not be found, weight-based doses from children's cystic fibrosis trials, and S-acetyl glutathione labels, which are a different molecule. [30], [28], [23], [37], [38], [39]
What is glutathione commonly used for?
Most people who look into glutathione want one of a few things: lighter or more even skin, a healthier liver, more energy or better recovery from a long illness. Skin lightening is one of the most heavily marketed uses, particularly in South and Southeast Asia, where regulators have warned about lightening drips offered by salons, spas and clinics. [13], [40], [41]
The body already makes its own glutathione, so the real question is whether taking more changes anything you would notice. Most of the studies below were small, and several measured blood levels rather than how people felt or looked.
A chart listing common uses of glutathione with the size, route, design and result of the largest human study for each. Placebo-controlled outcome trials in Parkinson's disease, chemotherapy nerve damage and cystic fibrosis found no clear benefit; a six-month oral trial raised blood glutathione; the only IV skin study was not randomized; no trial was found for daily energy, detox, hangovers or long COVID, although one eight-person exercise-fatigue study reported less fatigue.

Where the human evidence on glutathione is
Largest human study for each use
- Blood and cell glutathione levels (healthy adults)
- People in the study54RouteBy mouthDesignRandomized, placebo-controlledResultRose after 6 months at 250 and 1,000 mg a day
- Skin lightening (capsules)
- People in the study60RouteBy mouthDesignRandomized, placebo-controlledResultLower skin-darkness readings at 2 of 6 sites after 4 weeks
- Skin lightening (IV)
- People in the study32RouteIVDesignComparison group, not randomizedResult6 of 16 vs 3 of 16 improved; not significant; mostly gone at 6 months32 analysed (16 per group) of 50 enrolled
- Fatty liver
- People in the study29RouteBy mouthDesignNo comparison groupResultLiver enzyme (ALT) fell29 completed of 34 enrolled
- Type 2 diabetes
- People in the study250RouteBy mouthDesignRandomized (coin toss)ResultBlood glutathione rose; blood-sugar marker improved only in over-55s
- Parkinson's disease (IV)
- People in the study21RouteIVDesignRandomized, placebo-controlledResultNo clear benefit
- Parkinson's disease (nasal)
- People in the study45RouteNasalDesignRandomized, placebo-controlledResultNot better than placebo
- Chemotherapy nerve damage
- People in the study185RouteIVDesignRandomized, placebo-controlledResultNo benefit with paclitaxel and carboplatin
- Cystic fibrosis lungs
- People in the study153RouteInhaledDesignRandomized, placebo-controlledResultNo lung-function benefit
- Daily energy, detox, hangovers, long COVID
- No trial found (one 8-person exercise-fatigue study)
Blood-level and small studies reported changes; the larger placebo-controlled outcome trials mostly did not, and several popular uses have no trial.
Skin lightening, dark spots and melasma
People use capsules, creams, lozenges, injections and IV drips hoping for lighter skin, a “glow”, or faded dark patches such as melasma (brownish patches, often on the face). The studies found smaller effects than the marketing suggests. [42], [43]
A four-week trial of 500 mg a day found lower skin-darkness readings than placebo at two of six skin sites; a 12-week trial of 250 mg a day found no significant overall difference, and a capsule combining glutathione with vitamin C and other ingredients did no better than placebo. A lotion of oxidized glutathione lightened the treated side of the face in 30 women. The only IV study was not randomized, its result was not statistically significant, and its effect had mostly gone six months later. [16], [44], [45], [46], [27]
Japan's injection label lists melasma and other pigment disorders, based on older Japanese reports in which 87 of 146 people improved at least slightly. Regulators in the Philippines and Thailand have warned against IV glutathione for skin lightening. [3], [13], [40] See the skin studies in detail.

Liver health, fatty liver and “detox”
People with raised liver enzymes, fatty liver, heavy drinking or anabolic steroid use often try glutathione for “liver support”. Inside the liver it does help process some drugs and chemicals, which is where the “detox” idea comes from; that is normal biology, not proof that taking more clears toxins. [1], [5]
Small studies reported lower liver enzymes: 300 mg a day in people with fatty liver (with no comparison group), and daily IV glutathione added to hepatitis B treatment, where the 2025 study also reported better liver-stiffness and scarring scores. In a placebo-controlled trial of 61 people with cirrhosis, 500 mg a day by mouth for 12 weeks did not raise blood glutathione or improve antioxidant measures. None showed by tissue testing that liver damage reversed, and no trial has tested hangovers, mold illness, Lyme disease or a general “detox”. Japan's label includes chronic liver disease and certain poisonings. [47], [48], [49], [50], [3]
Energy, immunity and general wellness
Many people take it as a general antioxidant for energy, ageing and immunity. In the six-month oral trial, 1,000 mg a day more than doubled one immune-cell measure (natural killer cell activity) compared with placebo, and in eight men 1 g a day for two weeks lowered blood lactate and reported fatigue after a cycling test. No trial has measured fewer infections or more energy in daily life. [15], [51]
Parkinson's disease
An early open study of nine people reported improvement after IV glutathione, but a randomized, placebo-controlled IV trial found no clear benefit, and in a three-month nasal-spray trial neither dose did better than placebo. [52], [26], [53]
Chemotherapy nerve damage
This is glutathione's main use as an approved medicine: Italy's injection is licensed to prevent nerve damage from cisplatin and related drugs. Small cisplatin and oxaliplatin trials found less nerve damage, but the largest trial, with paclitaxel and carboplatin, found no benefit, and US cancer-specialist guidelines advise against it for that chemotherapy. [4], [54], [55], [56]
Lungs and breathing
Inhaled (nebulized) glutathione has been tested in cystic fibrosis, where the two largest trials found no clear improvement in lung function. In eight people with mild asthma, a single 600 mg nebulized dose narrowed the airways. [57], [58], [35]
Other uses you may come across
- Male fertility. Injections into a muscle improved sperm movement and shape in 20 men; pregnancy was not measured. [59]
- Blood sugar. In type 2 diabetes, 500 mg a day raised blood glutathione, but a blood-sugar marker improved only in a later analysis of people over 55. [60]
- Circulation and dialysis. Small IV studies reported longer pain-free walking in leg artery disease and higher red-cell measures on dialysis. [61], [62]
- Long COVID, chronic fatigue and mold illness. Common in community discussions, but untested; a two-person COVID-19 report used several treatments at once. [63]
See the human study results or explore the cell and animal research.
Where do glutathione protocols differ?
Glutathione numbers come from four different worlds: medicine labels, oral supplement trials, pharmacy and clinic pages, and IV drip menus.
Is the number per injection, per day or per week?
200 mg three times a week is 600 mg a week, while 200 mg a day is 1,400 mg a week. Injection pages switch between per-injection and weekly amounts, while oral amounts are almost always per day. [29], [22], [15] Vial labels add a second mix-up: “600 mg” or “1,500 mg” is the total powder in the vial, not the amount per millilitre, and community education groups describe people who misread it that way.
Where do the common numbers come from?
Most glutathione doses you will see online trace back to a handful of sources, and only two of them come from medicine labels, both for specific medical uses.
A diagram tracing six commonly quoted glutathione doses to their origins: the Japanese injection label (100–200 mg once daily), a six-month oral trial (250–1,000 mg a day), no study for the online 200 mg one-to-three-times-weekly injection schedule, the Italian TAD label's 600 mg option for long treatment, a non-randomized IV skin study (1,200 mg) and a Parkinson's trial (1,400 mg IV) that found no clear benefit.

Where the common glutathione doses come from
Six common numbers, traced
- 100–200 mg once dailyInto a muscle or vein
- OriginJapanese Tathion injection labelOrigin typeMedicine labelShowedLicensed for poisoning, liver disease, skin and other conditions
- 250–1,000 mg a dayBy mouth
- OriginSix-month randomized trial in 54 healthy adultsOrigin typeRandomized trialShowedRaised blood and cell glutathione; health outcomes not measured
- 200 mg per injection1–3 times a week, into a muscle or subcutaneous
- OriginNone found for this weekly schedule; matches 200 mg per mL compounded vialsOrigin typeUntested scheduleShowedJapan's label separately allows 100–200 mg once daily
- 600 mgIV or into a muscle
- OriginItalian TAD label: lower-dose option for long treatmentOrigin typeMedicine labelShowedLicensed only to prevent nerve damage from cisplatin-type chemotherapy
- 1,200 mgIV
- Origin2016 skin study (mixed with vitamin C and collagen)Origin typeNon-randomized studyShowedNot statistically significant; effect mostly gone at 6 months
- 1,400 mgIV
- Origin2009 Parkinson's trialOrigin typeRandomized trialShowedNo clear benefit over placebo
Only two of these numbers are label doses, both for specific medical uses; the popular 200 mg weekly injection schedule has never been tested.
- 250–1,000 mg a day by mouth: the two arms of the six-month oral trial. [15]
- 200 mg one to three times a week: no study of this website schedule was found; it matches the common 200 mg per mL compounded vial. Japan's label separately allows 100–200 mg once a day into a muscle or vein. [21], [24], [3]
- 600 mg IV or into a muscle: the Italian TAD vial, which its label allows for long chemotherapy courses. [4]
- 1,200 mg IV: the non-randomized skin study's mixed product. [27]
- 1,400 mg IV: the Parkinson's trial, which found no clear benefit. [26]
Why are IV doses so much larger than oral doses?
Clinics list IV sessions of 600 to 3,000 mg, while the oral trials used 250–1,000 mg a day. The common IV amounts trace to a cancer-care medicine, a Parkinson's trial and one small skin study, none of which tested wellness use, and IV glutathione leaves the blood within minutes. [64], [65], [4], [26], [27], [66]
Into a muscle or subcutaneous?
The licensed Japanese and Italian injections are labeled for a muscle or a vein, not for subcutaneous use. Injection pages list both, and people mostly choose by comfort, often moving to intramuscular injection because of stinging, welts and lumps. No study has measured absorption from either route in people, so the percentages quoted online have no study behind them. [3], [4], [30], [21]
Start low and build up, or start at the full dose?
The labels and trials start at the full amount. Step-up plans come from websites and community groups: one page increases from 100 to 200 mg a day over eight weeks. [3], [15], [28] In community education groups, a 50 mg, 100 mg, 200 mg build-up is copied widely from a single educator's post meant to avoid feeling unwell.
Those posts treat feeling ill after a dose as “detox”, but reactions to glutathione injections can be allergic or caused by a contaminated product, and building up slowly fixes neither. See what these reactions can mean.
How long, and are breaks needed?
The oral trials ran continuously for 4 weeks to 6 months. Injection pages describe 4–8-week courses, or up to 12 weeks followed by at least 4 weeks off. No study has tested breaks or very long use, and the Japanese label simply adjusts treatment to symptoms. [15], [23], [31], [3] Community education groups describe people injecting continuously for years.
Where do the sources disagree most?
- Amount and frequency: 100 to 600 mg per injection, from daily to once a week; none of these schedules has been tested for wellness or skin. [29], [31], [21], [28], [25]
- Course length: fixed courses of 4–12 weeks versus open-ended use. [23], [31]
- Inconsistent pages: an IV dose paired with an insulin syringe, vial counts that do not cover the page's own schedule, and a Parkinson's schedule printed as twice a week when the study used three times. [30], [28], [67]
Do liposomal, S-acetyl, sublingual and nasal products use the same amounts?
No, and their amounts cannot be swapped with ordinary capsules or injections.
- Liposomal: 500 or 1,000 mg a day in a 12-person study; labels commonly give 500 mg a day. [68], [69]
- Sublingual (held under the tongue): 150 mg three times a day in a 20-person trial. [70]
- S-acetyl glutathione: labels give 100–200 mg a day, but it is a different molecule. [39], [71]
- Nasal spray: 100 or 200 mg three times a day in Parkinson's trials, which one page doubles by quoting it “per nostril”. [53], [23]
- Nebulized (breathed in as a mist): 600 mg in the asthma study that narrowed airways; one clinic protocol gives 300 mg twice a day. [35], [72]
How do milligrams convert to syringe units?
Many people measure injections on an insulin syringe. A U-100 syringe has 100 units per millilitre, so units measure volume, not an amount of glutathione. How much glutathione each unit holds depends on how much liquid was added to the vial (reconstitution).
For example, a 600 mg vial mixed with 3 mL of liquid holds 200 mg per mL, so each unit holds 2 mg and 200 mg is 100 units, a full 1 mL syringe. The same vial mixed with 2 mL holds 300 mg per mL, and 200 mg is about 67 units. [23], [24], [28] Doserly's reconstitution calculator works this out for any vial and shows each step.
Source-by-source comparison and registered study plans
What do the pages actually say?
Unit key: 1 gram (g) = 1,000 milligrams (mg).
Strive Pharmacy suggests 200 mg (1 mL) into a muscle or subcutaneous once or twice weekly, or 100 mg (0.5 mL) every other day, and 500 mg as a slow IV push over 3–5 minutes. StemVera Health lists 200 mg or 400 mg into a muscle up to three times weekly for four weeks. Rebody Health lists 100 units (200 mg) subcutaneous up to three times a week. [21], [22], [24]
Longeva describes a start of 200–600 mg once or twice weekly and maintenance of 600–1,200 mg a week split over two or three injections. Peptalia describes 200–600 mg for 4–12 weeks with at least 4 weeks off. PeptideDosages describes a daily subcutaneous build-up from 100 to 200 mg over eight weeks. [29], [31], [28]
For IV use, PeptideWiki lists 600–1,200 mg once or twice weekly for 4–8 weeks; clinic menus range from 600 mg pushes to 2,000–3,000 mg sessions. [23], [64], [65], [73]
Is that a consensus?
No. Repeated numbers travel between pages and clinics, so counting matching pages overstates the support. None of these pages cites a study that tested its injection schedule. [67], [21], [22]
What are the registered studies?
These are registry records checked on September 23, 2026.
Glutathione alone or with vitamin C and NAC, weekly for 8 weeks
A placebo-controlled crossover study of 24 children with autism and severe behaviour problems. Results were submitted to the registry but have not been posted, and no publication was found.
Completed. Results submitted, not posted.
[74]100 mg twice daily for 4 weeks
A randomized crossover study in 16 men who smoked or had high blood pressure, measuring blood-vessel function. No results were posted and no publication was found.
Completed. No results posted.
[75]1,400 mg over 10 minutes, three times a week for 4 weeks
The registry record of the randomized Parkinson's trial described in this guide. The trial was published; the registry has no posted results. Its structured fields list 20 participants and a crossover design, while its own description and the paper describe a parallel trial (21 randomized); it was registered in 2010, after the trial ended.
Completed and published. No registry results posted.
[76]500 mg capsule a day for 12 weeks, as registered
The registry lists 90 women and a 500 mg glutathione capsule. The published paper reports 83 who finished and says the capsule also contained vitamin C, alpha-lipoic acid and zinc. It found no significant difference from placebo.
Completed and published.
[77], [45]What happens when you stop glutathione?
There is no evidence of a withdrawal effect or rebound, but no study has looked for one directly. What studies do show is that most measured changes fade once people stop. [15], [27]
- Blood levels. A month after six months of capsules, most measures had moved back toward baseline, though whole-blood levels in the 1,000 mg group were still higher. Nobody tested whether the body's own production drops after stopping. [15]
- Skin. In the IV skin study, 6 of 16 treated people had lighter skin at the end and one did six months later. A dermatology review calls the oral and topical effects reversible, and many public accounts say brightening faded. [27], [43], [78], [79]
- Parkinson's disease. An open study reported improvement lasting two to four months after IV glutathione; in the placebo-controlled trial, scores after stopping did not differ clearly from placebo. [52], [26]
- Dialysis. Red-cell measures that rose during IV glutathione fell back after stopping. [62], [80]
- Side effects. Rare skin rashes after muscle injections went away when treatment stopped, and a nasal-trial participant's racing heart settled after stopping. [4], [53]
Do oral and IV glutathione behave the same way?
No. Swallowed glutathione meets digestion and the gut wall before any of it reaches the blood, while an intravenous dose goes straight into a vein, and intramuscular, subcutaneous, nasal and inhaled doses each start somewhere else. Their amounts are not interchangeable.

Is oral glutathione absorbed?
Months of daily capsules can raise glutathione in blood and cells, but human studies have not shown how much swallowed glutathione crosses the gut intact rather than as its building blocks. How much of a dose reaches the blood is called bioavailability. [81], [15], [36]
- One large dose. When seven healthy people swallowed about 3 g, their blood glutathione did not rise over the next four and a half hours. [81]
- One dose, a different measure. A study of 50 mg per kilogram found a rise in the portion of blood glutathione attached to proteins, but not in the free form. [82]
- Months of daily use. In the six-month trial, 1,000 mg a day raised glutathione by 30–35% in red cells, plasma and immune cells and by 260% in cells scraped from the inside of the cheek; 250 mg a day raised whole-blood and red-cell levels. [15]
- Four weeks. A separate trial of 500 mg twice daily for four weeks found no change in red-cell glutathione or oxidative stress markers. [36]
In rats, much of a swallowed dose enters the blood heading to the liver unchanged, according to the Japanese tablet label. So “oral glutathione is never absorbed” is too absolute, but how much crosses the gut intact in people is not settled. [7], [83], [84]
How long does glutathione stay in the blood?
Not long. Half-life is the time it takes for a blood level to fall by half. After a large IV infusion in ten healthy volunteers, plasma glutathione rose more than 40-fold and then halved about every 14 minutes, while glutathione in urine rose about 300-fold; a second study measured about 10 minutes. [66], [85]
That does not settle whether glutathione enters cells or how long any effect lasts. Plasma cysteine rose sharply while total cysteine-containing compounds in plasma fell, which the researchers took as a sign that cysteine released from glutathione was being taken up by cells. No half-life has been measured after injections into a muscle or subcutaneous. [66]
Is liposomal, micellar or S-acetyl glutathione better?
Each of these is marketed as better absorbed. The evidence is product-specific and small.
- Liposomal: 500 or 1,000 mg a day raised whole-blood glutathione 40% in 12 adults, with no plain-capsule comparison; one 2026 product study reported about six times the peak blood level of plain glutathione, with six people per group. [68], [86]
- Micellar: 300 mg gave more whole-blood exposure than 500 mg of standard glutathione in 14 adults; one product, unequal doses. [87]
- Sublingual: improved the balance of active to used glutathione more than swallowed capsules in 20 adults. [70]
- S-acetyl glutathione: a single 3.5 g dose raised plasma glutathione more than standard glutathione; it is a separate molecule with its own European safety review. [88], [89]
None of these studies measured a health outcome, and none shows that a formulation works as well as an injection.
Does nasal or inhaled glutathione reach the brain or lungs?
After a single 200 mg intranasal dose in 15 people with Parkinson's disease, brain-scan glutathione readings had not risen at 8 minutes but were higher from about 20 minutes to the last scan at about an hour, with no comparison group; the later placebo-controlled trial found no benefit. [90], [53]
Nebulized glutathione reaches the airways, raising levels in lung fluid three- to fourfold an hour later, but the same route narrowed the airways of people with mild asthma, and FDA has named IV and inhaled glutathione as significant safety concerns. [91], [35], [1]
Does taking vitamin C with glutathione matter?
Vitamin C is often added to glutathione, especially in IV drips, and many people believe glutathione does not work without it. The oral trials that raised blood glutathione used glutathione alone. [15], [79], [92]
Mixing the two in one solution may also shorten its life: in a laboratory test of eye-drop solutions, glutathione broke down faster when vitamin C was added. The Philippine regulator also warns that IV vitamin C carries its own risks, including kidney stones and problems in people with G6PD deficiency, an inherited enzyme deficiency that affects red blood cells. [93], [13]
How should glutathione be stored, and how long does it last?
Official labels treat glutathione powder as stable and mixed glutathione as short-lived. Dissolved in water, glutathione slowly breaks down and reacts with oxygen. [3], [94], [95]
- Licensed powder, before mixing. Japan's injection powder and tablets keep for three years at room temperature, and Italy's injection for three years with no special storage condition. [3], [7], [4]
- After mixing. Japan's label says to use the injection immediately after dissolving it; Italy's allows 8 hours at room temperature, and an older Chinese insert 2 hours at room temperature or 8 hours at 0–5 °C. The Italian label says to discard a solution that looks cloudy or has particles. [3], [4], [96]
- Compounded multi-dose vials. US sterile-compounding rules allow up to 28 days after the first needle puncture only for vials prepared and tested as multi-dose products, or less if the pharmacy's own date is earlier. That is a sterility limit, not a storage period for a mixed single-dose vial or proof that the glutathione stays at full strength. [97]
- What stability tests show. In a patent's tests, one buffered 180 mg per mL solution at 25 °C lost 10% of its glutathione by day 21 and about a third by day 74, while a different buffered solution at 5 °C kept 98% for 112 days; glutathione is most stable between pH 5 and 7.5 with oxygen kept out. These tests measured strength, not sterility, and do not set storage times for other products. [94], [95]
- Supplements. One liposomal liquid maker says to keep it refrigerated and use it within 30–60 days of opening. [98]
Vendor and pharmacy pages that give 7 to 30 days in the fridge after mixing do not publish product-specific testing; one quotes potency figures from a study that could not be found. [99], [100] The nasal Parkinson's study did test its compounded spray: one sample had 72% of its intended strength after four weeks and another batch 80.5% after six weeks. [90] No published study has tested glutathione mixed into saline or vitamin drips for longer use. This guide does not cover mixing or injection technique; the Academy note below covers practical handling.
What do we actually know about glutathione in people?
More than for most compounds sold alongside peptides: over 60 published human studies have given people glutathione. Most were small or short, and many measured blood levels or lab markers rather than how people felt, looked or functioned. The larger and better-controlled a study was, the less it tended to find.

What did the oral studies find?
| Study | What researchers reported | What it cannot establish |
|---|---|---|
| Healthy adults, 6 months, 2015 | In a randomized, placebo-controlled trial of 54 adults, 250 mg and 1,000 mg a day raised glutathione in blood and cells, most at the higher dose; minor side effects were about as common as on placebo. [15] | Whether higher levels improve health; it measured body stores and immune markers only. |
| Healthy adults, 4 weeks, 2011 | 500 mg twice daily in 40 adults did not change red-cell glutathione or oxidative-stress markers. [36] | Whether a longer course would. |
| Skin, 4 weeks, 2012 | 250 mg twice daily in 60 people lowered skin darkness readings more than placebo at two of six sites. [16] | Whether the change is visible or lasting. |
| Skin, 12 weeks, 2017 | 250 mg a day of glutathione or its oxidized form in 60 women changed some skin measures; two people left with raised liver enzymes. [44] | A clear overall lightening effect. |
| Skin, combination capsule, 12 weeks, 2021 | A capsule with 500 mg glutathione plus vitamin C, alpha-lipoic acid and zinc did no better than placebo in 83 women. [45] | That glutathione alone works or fails; it was a combination. |
| Fatty liver, 4 months, 2017 | 300 mg a day lowered a liver enzyme, alanine aminotransferase (ALT), in 29 people. [47] | Anything about cause: there was no comparison group, and everyone first changed diet and exercise. |
| Liver cirrhosis, 12 weeks, 2020 | In a randomized, double-blind, placebo-controlled trial of 61 people, 500 mg a day, alone or with vitamin B6, did not raise blood glutathione or change oxidative-stress and antioxidant measures compared with placebo; no serious side effects were reported. [50] | Whether it helps cirrhosis itself; cirrhosis severity scores did not differ after 12 weeks, but the trial was short, the groups were small (14 to 18 people) and its main aim was blood antioxidant measures. |
| Type 2 diabetes, 6 months, 2022 | 500 mg a day raised blood glutathione and lowered a DNA-damage marker in 250 people; a blood-sugar marker improved only in a later analysis of people over 55. [60] | Better diabetes control. Group assignment was by coin toss and the benefit came from a subgroup. |
| Children with cystic fibrosis, 2015 and 2020 | A small trial reported better growth; a larger trial of 60 children found no difference from placebo. [101], [102] | Benefit, given the larger trial. |
What did the injection and IV studies find?
| Study | What researchers reported | What it cannot establish |
|---|---|---|
| Skin lightening, IV, 2016 | 1,200 mg with vitamin C and collagen twice weekly for six weeks: 6 of 16 treated people versus 3 of 16 in the comparison group had lighter skin readings; the paper reported p=0.054, which is not statistically significant, and does not fully explain its analysis. One treated person kept the change at six months. Of 25 treated, 8 had abnormal liver tests and 1 had anaphylactic shock. [27] | A fair comparison: treatment went to those willing to pay, many dropped out, and the product was a mixture. |
| Parkinson's disease, IV, 2009 | 1,400 mg three times a week for four weeks in 21 people: a 2.8-point difference on a symptom scale that could easily be chance. An earlier open study of 9 people had reported improvement. [26], [52] | Any benefit; the trial was small and short. |
| Chemotherapy nerve damage, IV, 1995–2014 | Small cisplatin and oxaliplatin trials found less nerve damage, for example 4 of 24 versus 16 of 18 people at 15 weeks. The largest trial, 185 people on paclitaxel and carboplatin, found no benefit. [54], [103], [55] | That it prevents nerve damage with every chemotherapy. Cancer guidelines advise against it for paclitaxel and carboplatin. [56] |
| Male infertility, into a muscle, 1993 | 600 mg every other day for two months in 20 men improved sperm movement and shape compared with placebo. [59] | More pregnancies; that was not measured. |
| Hepatitis B, IV, 2017 and 2025 | 1.2 g a day added to standard care lowered liver enzymes more than standard care alone. [48], [49] | Lasting benefit; there were no placebo infusions. |
What did the nasal and inhaled studies find?
- Nasal, Parkinson's disease. 100 or 200 mg three times a day for three months, tested for safety in 30 people and against placebo in 45: everyone improved, including the placebo group. One person on the higher dose left with a racing heart and a newly found heart-muscle problem; the authors could not say whether it was related. [104], [53]
- Inhaled, cystic fibrosis. Six months in 153 people and 12 months in 105 people did not clearly improve lung function. [57], [58]
- Inhaled, asthma. A single 600 mg dose narrowed the airways in eight people with mild asthma, although another study found a dose protected against a “fog” challenge. [35], [105]
Does a higher blood level mean a health benefit?
Not necessarily. Across the evidence, studies of blood levels and lab markers often reported changes, while studies of symptoms, function or disease against placebo mostly did not. When you read that glutathione “works”, check which kind of result is meant. [15]
Why do sources describe the IV skin study so differently?
Because each repeats part of the story. FDA's 2022 review called it placebo-controlled; the Philippine regulator said in 2019 that no such trial existed. The original report shows a comparison group, but allocation by willingness to pay, heavy dropout and a mixed product. Reviews of the skin studies agree that the evidence is limited and the effects modest, and one describes them as reversible. [1], [13], [27], [42], [43], [41]
What do pooled analyses say?
A 2014 Cochrane review of seven glutathione trials during platinum chemotherapy (387 people) found fewer cases of moderate nerve damage on a symptom-based grading scale, but too little evidence from objective nerve tests to be sure. A 2021 analysis of seven Parkinson's trials (450 people) found a small improvement on one movement scale but not on others, across different routes and study quality. [106], [107]
How does glutathione work?
What glutathione does inside the body is well understood; what taking extra glutathione changes is much less clear.
What does glutathione do inside cells?
- Antioxidant recycling. Reduced glutathione (GSH) neutralizes reactive oxygen molecules and becomes oxidized glutathione (GSSG). An enzyme then turns GSSG back into GSH, so the same molecules are used again and again. The balance of GSH to GSSG is used in research as a measure of oxidative stress. [1], [5]
- Clearing chemicals. Glutathione can be attached to some drugs, toxins and waste products so the body can remove them in urine or bile. This is the real biology behind “detox” marketing, and it is one reason Japan's label includes certain poisonings. [3], [1]
- Making it. Cells build glutathione in two steps from glutamate, cysteine and glycine. The supply of cysteine usually limits how much they can make, which is why the precursor NAC, a form of cysteine, is often used instead. [5]
What happens to glutathione that comes from outside?
Outside cells, glutathione is mostly taken apart by the enzyme GGT into its building blocks, which cells then take in and use to rebuild their own glutathione. In rats given glutathione into a vein, radioactive tags from it collected first in the kidneys. That helps explain why IV glutathione disappears from blood within minutes and why a rise in blood levels does not prove that intact glutathione entered cells. [5], [108], [66]
“Detox” claims also need care: in mice given arsenic, glutathione injections changed where the arsenic went, and in rats it moved more mercury into the kidneys. Moving a toxin around is not the same as removing it safely. [109], [110], [111]
How might it affect skin colour?
Skin colour depends on melanin, made by pigment cells called melanocytes through a chain of reactions that starts with the enzyme tyrosinase. Melanin comes in a darker brown-black type (eumelanin) and a lighter red-yellow type (pheomelanin). [1], [112]
- In test tubes, glutathione blocked melanin formation from one of tyrosinase's products at higher concentrations, while at low concentrations it activated one step of the reaction. [112], [113]
- In pigment cells, glutathione interrupted early melanin production in mouse melanoma cells, but in another cell study glutathione itself did not lighten cells while a modified version did. [114], [115]
- In animals, glutathione by mouth lowered melanin after UV exposure in mice, and injections into the abdomen lightened UV-darkened skin in guinea pigs. [116], [117]
- The theory most often given is that glutathione shifts production toward the lighter pheomelanin. Regulators note a theoretical concern that this shift could raise long-term skin cancer risk; that has not been shown in people. [1], [13]
Why doesn't the biology guarantee a benefit?
Because the body already makes and recycles glutathione, and glutathione from outside is largely broken down before it reaches cells. Lab and animal results also used amounts and routes people do not use; the research library summarizes them with their limits. [15], [36], [66]
What are the risks and unanswered questions?
Is glutathione safe?
Swallowed glutathione has a good short-term record: 250–1,000 mg a day was well tolerated in trials of up to six months. Injected and IV glutathione carries more risk, including rare severe allergic reactions, abnormal liver tests in the IV skin study and repeated illness clusters from contaminated compounded products. [15], [3], [27], [33]
The trials were small and short, so they could miss uncommon or slow-developing problems, and most injections people buy were never made as medicines.
What side effects have been reported?
Capsules. In the six-month trial, minor complaints were about as common on placebo (20 reports) as on 250 mg (18) or 1,000 mg (19). Other trials recorded wind, loose stools, bloating and nausea, and two people in a skin trial stopped because of raised liver enzymes that returned to normal. Japan's tablet label lists rash, loss of appetite, nausea, vomiting and stomach pain, each in fewer than 1 in 1,000 people, and a 2021 case report linked a severe blistering skin reaction to whitening pills. [15], [36], [87], [44], [7], [118]
Injections and IV.
- Labels. Japan's injection label lists anaphylaxis (a severe allergic reaction) in fewer than 1 in 1,000 people, plus rash, loss of appetite, nausea and vomiting. Italy's lists rare rashes and injection-site pain after muscle injections. In 2018 China added allergic shock, breathing problems, chest pain, chills, fever, palpitations and flushing to glutathione injection labels. [3], [4], [119]
- The IV skin study. Of 25 people treated, 11 felt warmth, 10 had cramps, 8 had abnormal liver tests and 1 had anaphylactic shock. [27]
- Reports and case reports. A Chinese review collected 27 published reports of anaphylactic shock (30 patients) after glutathione injections, and FDA's reporting system held reports of anaphylaxis, liver injury and infusion reactions after IV glutathione. Single cases describe a life-threatening asthma attack after a cosmetic IV dose, an allergy-triggered heart problem, a severe whole-body inflammatory reaction after a “revitalising” drip, and a severe skin reaction after IV glutathione with vitamins. [120], [1], [121], [122], [123], [124], [125]
Nasal and inhaled use. In the nasal Parkinson's trial, one participant developed a racing heart and a heart-muscle problem. Inhaled glutathione narrowed the airways of people with mild asthma. [53], [35]
These reports cannot tell us how often problems happen, and several involved mixtures, but they show that “it's natural, so it's harmless” is not a safe assumption for injections.
Is feeling ill after a dose a “detox” reaction?
There is no evidence for it. Public forum posts describe flu-like symptoms or a “crash” after a dose as toxins being released, and advise lowering the dose and continuing. [126], [127] Community education groups describe the same belief. No study has measured toxins leaving the body after glutathione, and the symptoms people describe have better-documented causes. [1], [33]
- Allergic reactions. The Japanese and Chinese labels warn about anaphylaxis, and the Italian label lists allergy to glutathione as a reason not to use it. Believing that nobody can be allergic to glutathione is wrong. [3], [119], [4]
- Contaminated products. Bacterial toxins (endotoxin) in injectable glutathione have caused fever, chills, shaking, nausea, vomiting, body aches, light-headedness, breathing difficulty and low blood pressure within minutes to hours of a dose. [8], [33], [34]
Chinese labels say to stop an injection immediately and treat the person if wheezing, chest tightness, fast or difficult breathing, palpitations, heavy sweating or falling blood pressure appear. Those are reasons for urgent medical help, not signs that glutathione is working. [119]
Could product quality change the risk?
Yes, and for injections this is the best-documented risk. Much of the glutathione injected outside hospitals is compounded or sold as a “research” powder, and outbreaks have been traced to supplement-grade ingredients contaminated with endotoxin. [8], [33]
- Australia (reported 2018): seven people fell ill with fever and shaking chills after compounded infusions, five of them treated for Lyme disease. [128]
- United States, 2019: seven patients at one clinic, each given 1,400 mg IV, reacted within minutes; one was hospitalized. Endotoxin was up to five times the appropriate limit. [8]
- Canada, 2021: Health Canada warned about an unauthorized glutathione injection with high endotoxin. [129]
- United States, 2026: FDA reported at least 30 patients with fever, chills or signs of shock after IV glutathione made with one supplement-grade ingredient lot; some were hospitalized. Three pharmacies recalled products, and the CDC counted more than 25 ill people in at least four states after IV, subcutaneous or intramuscular doses. [33], [130], [131], [132], [34]
A product labelled “research use only” has not been tested for sterility or endotoxin to medicine standards.
Is glutathione legal? Is it FDA-approved?
Checked September 23, 2026. Rules differ by country and by product, and they change.
United States. Glutathione is sold as a dietary supplement ingredient and is not an FDA-approved drug. Recent steps for injectable glutathione:
- 2009. FDA raised no questions about a notice that glutathione is safe in foods at up to 742.5 mg per serving; that covers food, not injections. [9]
- June 2022. FDA staff recommended against adding glutathione to the list of ingredients pharmacies may use for compounding, citing IV and inhaled safety concerns; the advisory committee voted 8 to 5, with 1 abstention, to add it. The vote was advice, not a decision. [1], [133]
- 2025–2026. Glutathione remains “under evaluation” (Category 1) for both kinds of compounding pharmacy; FDA has not decided. [10], [134]
- August–September 2026. FDA warned compounders against supplement-grade glutathione in injections, products were recalled and the CDC began tracking an outbreak. [33], [131], [34]
Canada. Oral L-glutathione is a permitted natural health product ingredient. Health Canada's antioxidant monograph, a licensing guide for oral products, lists a 743 mg daily maximum and advice to ask a practitioner before use in pregnancy or breastfeeding. Health Canada's drug database lists no authorized glutathione injection, and Health Canada has warned about or recalled compounded glutathione injections and IV drips sold without authorization, in 2021 and again in 2025. [32], [135], [136], [129], [137]
Australia. Glutathione for injection or infusion is a prescription-only (Schedule 4) medicine, and IV drips containing it may not be advertised to the public. Oral products fall outside that entry, but separate rules for listed (over-the-counter) medicines allow glutathione as an active ingredient only by mouth, for adults, with a label warning against use in pregnancy and breastfeeding. [138], [139], [140]
Elsewhere.
- Japan licenses glutathione injections, which are prescription-only, and tablets, which are listed outside the prescription-only category. Italy licenses an injection to prevent nerve damage from cisplatin-type chemotherapy. [3], [7], [4]
- The Philippines approves injectable glutathione only alongside cisplatin chemotherapy, and a licensed South Korean injection is approved to prevent nerve damage from cisplatin-type drugs; both regulators treat skin whitening as unapproved or off-label. [13], [141], [142]
- Thailand has no registered glutathione medicine and has not certified cosmetic injections as safe. [40]
- United Kingdom: the advertising regulator ruled in 2023 against IV drip ads claiming skin brightening. [143]
- European Union: a 2026 European Food Safety Authority opinion covered S-acetyl glutathione, not glutathione, and is not an authorization. [89]
“Research use only” wording does not make an injectable product legal to sell for use in people.
Is glutathione banned in sport?
Glutathione itself is not on the World Anti-Doping Agency Prohibited List for 2026 or 2027. The IV method rule still applies: infusions or injections of more than 100 mL in a 12-hour period are banned in and out of competition, unless given in hospital, during surgery or for clinical tests. Clinic drips diluted in 250 mL of fluid exceed that volume. [144], [145], [64], [73]
Can glutathione feed cancer or interfere with cancer treatment?
Nobody knows. There is no evidence that taking glutathione causes cancer, but there are specific reasons for caution around existing tumours and cancer treatment. [1]
- Chemotherapy. IV glutathione given with oxaliplatin lowered platinum levels in the blood in one trial. Small trials did not report weaker tumour responses, but were not designed to test that, and animal studies are mixed. In the lab, added glutathione helped some cancer cells resist cisplatin. [146], [54], [147], [148], [149], [150]
- Radiotherapy. FDA noted the theoretical concern that an antioxidant could protect tumour cells during radiation treatment. [1]
- Tumours using glutathione from their surroundings. A 2026 study in cancer cells and mice found that tumours break down glutathione outside cells to get cysteine, that adding glutathione rescued cancer cells starved of cysteine in a dish, and that blocking the enzyme GGT slowed tumour growth in mice. It did not give glutathione to animals or people, so it does not show that supplements feed tumours, but it adds to the reasons for caution in people with cancer. [151]
For anyone with a current or past cancer, especially during chemotherapy or radiotherapy, this is a question for the treating oncologist.
Who should be especially cautious?
These groups either had specific warnings in labels or were not studied. That is a reason for caution, not proof of harm.
- Pregnancy and breastfeeding. There are no human safety studies. Japan's labels ask prescribers to weigh continuing breastfeeding, and Canada advises asking a practitioner first. Italy's label says that, because cells make glutathione naturally, it does not cause problems in pregnancy or breastfeeding, but it cites no human studies. Japan lists severe pregnancy sickness as an indication, which is not safety evidence either. [3], [32], [4]
- Asthma. Inhaled glutathione narrowed the airways in mild asthma, and China's injection labels advise caution with past asthma attacks. [35], [119]
- Cancer and cancer treatment. See the question above. [56]
- Earlier reactions. Allergy to glutathione is the Italian label's listed reason not to use it. [4]
- G6PD deficiency. Glutathione drips with high-dose vitamin C carry extra risk in this inherited condition, according to the Philippine regulator. [13]
- Under 18. Safety in children is not established for the Italian injection; this guide is written for adults. [4]
- Athletes and people taking other medicines. See the sport and interaction questions. [144]
Has glutathione been tested alongside other medicines?
Very little. The Italian label says no drug interactions have been described, but one trial found lower platinum levels when glutathione was given with oxaliplatin. In a laboratory test, glutathione for injection was physically incompatible (for example, turning cloudy) with 11 of 44 IV drugs when they met in a drip line, and the Italian label says not to mix it with other products. Bring a complete list of everything you take, including IV drips and supplements, to a pharmacist or doctor. [4], [146], [152]
What should be monitored while using glutathione?
No label requires routine blood tests for glutathione. What exists is label advice on watching for reactions and a record of what trials measured, which can help you prepare questions for a clinician; it is not a personal testing plan. [3], [4]
What do the labels ask for?
- Watch for reactions. Japan's labels say to observe patients carefully and stop if anything abnormal appears. China's labels say to ask about drug allergies, monitor closely during an injection and stop immediately for allergic signs. Italy's label says to stop an infusion if an immediate reaction occurs. [3], [7], [119], [4]
- Check the product. Italy's label says to inspect the mixed solution and not use it if it is cloudy or contains particles. [4]
- Injection sites. Japan's label says to avoid nerves, rotate sites and withdraw the needle if there is severe pain or blood comes back into the syringe. [3]
What did the studies check?
- Oral trials checked blood pressure, blood counts and liver and kidney tests, finding no significant changes over four weeks or 30 days; after two people in a skin trial had raised liver enzymes, its authors suggested blood tests even for over-the-counter use. [36], [87], [44]
- IV and nasal studies. The IV skin study checked liver tests every two weeks (abnormal in 8 of 25), and the nasal trial's authors suggested screening future participants for heart side effects. [27], [53]
Which signals matter, and why?
| Why it matters | What labels, studies or alerts flagged | Tracking category |
|---|---|---|
| Allergic and infusion reactions | Anaphylaxis, rash, flushing, breathing symptoms and low blood pressure after injections | Side Effect Burden; Blood Pressure; Heart Rate & Palpitations |
| Contaminated products | Fever, chills, nausea and light-headedness within minutes to hours | Temperature Regulation; Nausea & GI Tolerance |
| Liver | Abnormal liver tests in the IV skin study and one oral skin trial | Blood work |
| Breathing | Airway narrowing with inhaled glutathione in asthma | Other (breathing symptoms) |
| Injection sites | Pain, welts and lumps, especially subcutaneous | Side Effect Burden |
| The reason you are taking it | Skin tone, energy, liver enzymes or symptoms | Skin Health; Energy Levels; Blood work |
Some reports involved mixtures or contaminated products, so these signals show what to watch, not what glutathione itself will do. [27], [44], [35], [33] CDC advises anyone who develops fever, chills, severe body aches, nausea, vomiting, dizziness, or pain, swelling or redness at the injection site after a recent glutathione injection to contact a healthcare provider promptly, and to seek emergency care for difficulty breathing, fainting or signs of shock. [34]
What do people in public communities report?
Public forums and community education groups include people chasing lighter skin, athletes protecting their liver, people with long COVID or chronic fatigue, and people injecting glutathione alongside weight-loss drugs. Injection-site pain and noticing no change come up again and again, and recovery stories usually involve other treatments too.
What do the positive reports look like?
Skin. After three months of capsules, one person said a tan had mostly faded but saw no lightening beyond it; another, after 21 days, described less tan and dullness with their natural tone unchanged. [153], [154]
IV accounts are more dramatic, and busier. One person given 1,200 mg with vitamin C twice a week for three months described lighter skin and fewer acne spots before painful veins made them stop; another credited weekly drips while also avoiding the sun, wearing sunscreen and using acid lotions. [92], [155]
Liver and wellness. In a steroid forum, one person said raised liver enzymes fell to normal over two months of injections into a muscle; another reported a higher blood glutathione result after eight months. People describing more energy from injections were often also injecting NAD+, a molecule cells use in energy reactions. [156], [157], [158]
Chronic illness. One person cross-posted a recovery account to chronic fatigue and long COVID forums after taking S-acetyl glutathione, a different molecule, along with GABA and lymph-drainage massage, so it cannot isolate any one treatment. [159], [160]
How long did the changes last?
Skin changes often did not last. Many public accounts say brightening faded after stopping, and one person said the “hydrated” look after a drip lasted four to five days. [78], [79], [161] In community education groups, skin changes are described as taking about two months to appear. In the IV study, most lightening had faded six months later. [27]
Does everyone notice something?
No. Public accounts include no noticeable benefit from 200 mg three times a week, no visible change after two IV sessions, no glow after two months of capsules, and daily injections into a muscle with no noticeable benefit. [162], [78], [158] In community education groups, “nothing noticeable” after months of injections is one of the most common reports, and liposomal capsules drew several of these too.
Some educators answer that glutathione can work without any noticeable effect, but without a measurement an unnoticed effect cannot be told apart from no effect.
What about injection pain, welts and lumps?
This is the most common problem people describe: stinging for hours, itchy welts, hard lumps lasting days and numb patches after subcutaneous injections. Many found injections into a muscle less troublesome. [155], [163], [164], [165], [166] In community education groups, lumps occasionally last months.
People report less stinging with buffered products, room-temperature solution and slow injection. Unbuffered glutathione in water is strongly acidic (about pH 2.7 in one laboratory preparation), while the licensed Japanese and Korean injections add sodium bicarbonate as a buffer; the Japanese one is pH 5 to 7 once dissolved. [167], [3], [141]
Does feeling worse mean it is working?
Not according to any evidence. People with chronic fatigue or mold illness describe swollen glands, exhaustion, headaches or a “crash” after starting glutathione, often explained as detox, a “herx” reaction or sulfur sensitivity, none of which was measured. [168], [127], [126]
In community education groups, members describe a racing heart and flushing soon after an injection, chest heaviness, cramps with chills, and fever and aches after dose increases. These were usually called detox, but they match the allergic and contamination reactions in the risks section, which call for prompt medical attention.
What other unwanted effects come up?
Single accounts describe pins and needles in the legs the morning after an IV drip with vitamin C; cramps and a hangover-like headache in the weeks after a drip, during which the person also drank alcohol; acne breakouts on capsules; small rough bumps on the skin; and anxiety and poor sleep. [169], [170], [171], [172], [173] In community education groups, some describe headaches and insomnia with evening doses. These reports cannot show how often an effect happens or that glutathione caused it.
What goes wrong with doses and storage?
Public threads ask how to mix a 600 mg vial and how many vials a course needs. [174], [175] In community education groups, people have read a vial's total as the amount per millilitre, confused milligrams with micrograms, used pre-mixed liquids with no strength on the label, and been given unreliable per-injection amounts by AI chatbots. Mixed vials are commonly kept in the fridge for three to six weeks, while the licensed Japanese injection is to be used immediately. See storage.
How can you judge a glutathione story?
Ask what else changed. Public skin stories often included sunscreen, peels, lasers or red-light treatment. [155], [79] In community education groups, almost every story of liver enzymes returning to normal also involved large weight loss on a GLP-1 weight-loss drug (such as semaglutide), stopping a medicine known to strain the liver, or both, and energy stories often included NAD+ injections.
Also ask how the result was measured, what happened after stopping, and whether a reaction was explained away. Colds end, tans fade, and liver enzymes move with weight and exercise.
These selected discussions help identify questions and experiences worth studying. They are not a survey of all users, a response rate or a substitute for controlled studies.
How does glutathione compare with NAC, GlyNAC and NAD+?
NAC and GlyNAC come up as cheaper ways to help the body make its own glutathione, and NAD+ because it is often injected in the same routines. The table compares what each is and how much human evidence exists; it does not rank them.
| Compound | What it is | Route and typical use | Human evidence | Approval status |
|---|---|---|---|---|
| Glutathione (this guide) | A three-amino-acid molecule cells make themselves [1] | Capsules of 250–1,000 mg a day in trials; injections of about 200 mg one to three times a week on dosing pages; IV drips [15], [21], [23] | Many small trials; blood levels rise with months of capsules, but the larger outcome trials were negative [15], [26], [55] | Licensed in Japan and Italy; a supplement in the US, where injections are not FDA-approved [3], [4], [10] |
| NAC (N-acetylcysteine) | A form of cysteine, the building block that usually limits how much glutathione cells can make [5] | IV in hospital for paracetamol (acetaminophen) overdose; an oral solution for the same use; inhaled to loosen mucus; capsules sold as supplements [176], [177], [178] | An FDA-approved antidote for acetaminophen overdose [176] | An FDA-approved drug; FDA has said since 2022 it will not act against certain NAC supplements [178] |
| GlyNAC (glycine plus NAC; see glycine) | A combination of two glutathione building blocks [14] | By mouth; 100 mg per kilogram of body weight of each, daily, for 16 weeks in a trial of older adults [14] | Small trials in older adults with mixed results: a 16-week randomized trial in 24 found higher glutathione than placebo, while a 2-week randomized trial in 114 found no difference in its main blood measure [179], [14], [180] | Sold as supplements (NAC under FDA's 2022 policy); the combination is not an approved medicine [178] |
| NAD+ | An essential molecule in every cell's chemistry (a coenzyme) [181] | IV drips and injections; a pilot study infused 750 mg over six hours [181] | One small pilot in 11 men: blood levels rose only late in the infusion, with no side effects during it [181] | Not FDA-approved; under FDA evaluation for pharmacy compounding [10] |
The real differences are in what each compound is. NAC and glycine are raw materials for making glutathione, so their studies are not evidence about glutathione, and the reverse is also true. NAC is an FDA-approved medicine in the US, and glutathione is a licensed medicine in Japan and Italy. No trial has compared these compounds with each other for any everyday goal, and the idea that glutathione and NAD+ cancel each other out has not been tested. [176], [14], [5]
Common questions about glutathione
Is glutathione a peptide?
Technically yes: it is a chain of three amino acids, a tripeptide. But unlike BPC-157 or other signaling peptides, it is an everyday molecule that nearly every cell makes for itself. [1], [5] See what glutathione is.
Does oral glutathione work?
It can raise glutathione in blood and cells if taken for months, but it has not been shown to improve health. In the six-month trial, 250 or 1,000 mg a day raised levels, while a four-week trial of 1,000 mg a day found no change. Skin trials found modest changes at some sites, and liposomal products were tested only in small, product-specific studies. [15], [36], [16], [68] See whether oral glutathione is absorbed.
Is IV glutathione FDA-approved for skin lightening or detox?
No. Glutathione is not an FDA-approved drug for any use, IV glutathione is still under FDA review for pharmacy compounding, and FDA staff raised specific safety concerns about IV use. Japan's injection label does include melasma and other pigment disorders at 100–200 mg a day, which is very different from cosmetic whitening drips, and the Philippines and Thailand have warned against IV glutathione for skin lightening. [10], [1], [3], [13], [40] See the legal status summary.
How long does glutathione take to lighten skin, and does it last?
The skin trials measured changes after 4 to 12 weeks, and community accounts often describe about two months. The changes were modest and often faded after stopping: in the only IV study, one of 16 treated people still had lighter skin six months later. Sunscreen and sun avoidance, which many people use at the same time, also change skin tone. [16], [44], [27], [155] See what people reported over time.
Is IV glutathione better than capsules?
It reaches the blood faster, but that does not make it more effective. Blood levels spike and then halve within about 10–14 minutes. The IV skin study was not randomized, the IV Parkinson's trial found no clear benefit, and IV products carry allergy and contamination risks that capsules do not. [66], [27], [26], [33] See how the route changes exposure.
Is glutathione the same as NAC or S-acetyl glutathione?
No. NAC is a form of cysteine, a precursor the body uses to build glutathione, and an approved hospital drug. S-acetyl glutathione and oxidized glutathione (GSSG) are different molecules, so their evidence and amounts cannot be swapped with glutathione's. [176], [88], [12], [6] See the comparison.
Can you take glutathione with vitamin C or NAD+?
Many people do, but whether the combinations help or harm has not been established. The oral trials that raised glutathione levels did not add vitamin C; the only IV skin study used a glutathione, vitamin C and collagen mixture, so it could not show what vitamin C added; and vitamin C made glutathione break down faster in a lab solution. Italy's label says not to mix its injection with other products. No study has tested glutathione with NAD+. [15], [27], [93], [4] See why vitamin C comes up.
Is it safe to take glutathione every day for years?
That has not been studied. The longest trials of daily capsules lasted six months and found minor side effects about as often as placebo. Longer use, especially of injections, has no trial data, and the risks of injections (allergy, contamination, injection-site problems) repeat with every dose. [15], [60], [33] See the risks and cautions.
Glossary
Plain explanations of the route, dosing and research terms used in this guide. Underlined terms in the text link here.
- Adverse event
- A harmful or unwanted medical event reported after someone used a treatment. A report alone does not prove the treatment caused it.
- Alanine aminotransferase (ALT)
- A liver enzyme measured in routine blood tests. Higher levels can signal liver strain, but they also change with weight, alcohol, exercise and medicines.
- Amino acid
- A small chemical building block. Chains of amino acids make up peptides and proteins; glutathione is made from three: glutamate, cysteine and glycine.
- Anaphylaxis
- A severe, fast allergic reaction that can cause breathing difficulty, paleness and a drop in blood pressure. It needs emergency treatment.
- Animal study
- Research in animals such as rats or mice. It shows what a substance does in a living body, but results in people can differ.
- Antioxidant
- A substance that neutralizes reactive oxygen molecules that can damage cells. Glutathione is one of the body's own antioxidants.
- Bioavailability
- How much of a dose reaches the bloodstream in a usable form. It depends heavily on the route and the product.
- Cell study (in vitro)
- Research on cells grown in a dish or on chemicals in a test tube. It gives early clues about biology, but it is far from proof of benefit in people.
- Compounding
- When a pharmacy prepares a customized medicine from individual ingredients. In the US, FDA lists control which bulk ingredients pharmacies may use, and glutathione is still under review.
- Controlled trial
- A study that compares people who receive a treatment with a similar group who do not, often receiving a placebo instead. Randomly assigning people to each group (a randomized trial) makes the comparison fairer.
- Course and cycle
- A course is the period of repeated use, such as eight weeks. A cycle is a course plus a planned break before any further use.
- Daily total
- All the amounts given in one day, added together. For example, 500 mg twice daily is a 1,000 mg daily total.
- Dose (amount each time)
- The amount given on one occasion. A protocol lists both the dose and how often it is given.
- Endotoxin
- A toxin from the outer wall of certain bacteria. It is not removed by ordinary sterilizing, and in an injection it can cause fever, chills, low blood pressure and shock.
- G6PD deficiency
- An inherited condition in which red blood cells lack enough of the enzyme glucose-6-phosphate dehydrogenase, making them easier to damage with some medicines and high-dose vitamin C.
- Gamma-glutamyl transferase (GGT)
- An enzyme on the outside of many cells that breaks glutathione into its building blocks. It is also measured in routine liver blood tests.
- GSH and GSSG
- The two main forms of glutathione. GSH (reduced glutathione) is the active form; GSSG (oxidized glutathione, or glutathione disulfide) is the used form that cells recycle back into GSH.
- Half-life
- The time it takes for the measured level of a substance in the blood to fall by half. It is not the same as how long an effect lasts.
- Intramuscular (IM)
- Injected into a muscle.
- Intranasal
- Sprayed or dropped into the nose.
- Intravenous (IV)
- Given directly into a vein, as a quick push from a syringe or a slower drip, so it enters the bloodstream immediately.
- Liposomal
- A product in which the active ingredient is wrapped in tiny fat bubbles (liposomes), marketed to improve absorption. Results apply to the specific product tested.
- Melanin
- The pigment that gives skin, hair and eyes their colour. Eumelanin is brown-black; pheomelanin is lighter and red-yellow.
- Melasma
- Brown or grey-brown patches of skin, usually on the face, linked to sun exposure and hormones.
- mg and g
- Milligrams and grams. 1 g equals 1,000 mg, and 1 mg equals 1,000 micrograms (mcg). Glutathione amounts are usually written in mg.
- NAD+
- Nicotinamide adenine dinucleotide, a molecule every cell uses in energy reactions. It is sold as IV drips and injections and is a separate compound from glutathione.
- Nebulized
- Turned into a fine mist by a machine (a nebulizer) and breathed into the lungs.
- Oral
- Taken by mouth, as a capsule, tablet or liquid, and swallowed.
- Oxidative stress
- An imbalance in which reactive oxygen molecules outpace the body's antioxidant defences, which can damage cells.
- Peptide
- A short chain of amino acids. Glutathione is a chain of three (a tripeptide).
- Pharmacokinetics
- How the body absorbs, moves, breaks down and removes a substance.
- Placebo
- A dummy treatment with no active ingredient, used as a comparison in studies.
- Preclinical research
- Studies done before or outside research in people: cell studies and animal studies.
- Precursor
- A building block the body uses to make something else. NAC and glycine are precursors of glutathione.
- Reconstitution
- Mixing a freeze-dried powder with a liquid so it can be measured and injected. The amount of liquid sets how much glutathione each unit holds.
- Research use only
- A label on products sold for laboratory research. It does not mean a product is approved, tested for human use or legal to sell as a medicine.
- S-acetyl glutathione
- A modified form of glutathione with an extra chemical group, sold as a supplement. It is a different molecule, so its studies and doses do not transfer to glutathione.
- Schedule 4 (Australia)
- Australia's prescription-only medicine category. Glutathione for injection or infusion is listed there.
- Subcutaneous (SC)
- Injected into the fatty layer just under the skin. The licensed glutathione injections are not labeled for this route.
- Sublingual
- Held under the tongue to dissolve, rather than swallowed.
- Syringe units
- Markings on an insulin syringe that measure volume. On a U-100 syringe, 100 units equal 1 mL. The amount of glutathione per unit depends on the vial's concentration.
- Titration
- Adjusting a dose in steps, usually starting lower and increasing if needed.
- WADA
- The World Anti-Doping Agency, which publishes the list of substances and methods banned in sport.
- Withdrawal and rebound
- Withdrawal effects are symptoms caused by stopping a substance. A rebound is a problem returning worse than before after stopping. Neither has been studied for glutathione.
Explore more of the research
Go deeper into the cell and animal experiments behind the claims.
Across this guide, the citations include 84 original scientific papers: 53 human studies, 27 cell and animal studies and 4 laboratory stability or chemistry studies. The library below explores 26 of the cell and animal papers, grouped by the question they answer. Paper counts are not counts of independent research teams, and labels, registry records, reviews, websites and personal accounts are counted separately.
In the route details, “into the abdomen” means an injection into the abdominal cavity (intraperitoneal), a route used in animals, not people.
How the body handles glutathione from outside · 7 papers
Does swallowed glutathione raise liver levels?
Model: Fed and fasted rats and mice given 1 g per kilogram by mouth.
Finding: Liver glutathione rose in fasted rats, but the animals' own production contributed, so the study could not show that intact glutathione entered liver cells.
Limit: A very large dose, and results depended on feeding. It does not show what a supplement does in people.
Study details and access
Effect of oral glutathione on hepatic glutathione levels in rats and mice.
1989 · Selected original full-text sections reviewed.
Route context: By mouth, 1 g per kilogram.
Does swallowed glutathione reach the blood?
Model: Rats given glutathione by mouth as a single dose or in their food.
Finding: Plasma glutathione roughly doubled, from about 15 to 30 micromoles per litre, peaking 90–120 minutes after a dose.
Limit: Rat blood levels only; no tissue or health outcome.
Study details and access
Bioavailability of dietary glutathione: effect on plasma concentration.
1990 · Original abstract reviewed.
Route context: By mouth, single dose or mixed into food.
Do tissues take it up?
Model: Mice with normal or artificially lowered glutathione, given 100 mg per kilogram by mouth.
Finding: Blood levels rose, but clear rises in tissues were seen mainly in mice whose glutathione had been depleted first.
Limit: A depletion model; healthy animals changed less.
Study details and access
Oral glutathione increases tissue glutathione in vivo.
1991 · Original abstract reviewed.
Route context: By mouth, 100 mg per kilogram.
What form reaches the liver?
Model: Rats given glutathione labelled with a tracer, with NAC as a separate comparison.
Finding: Tracer from swallowed glutathione reached the gut wall and liver, but in blood it appeared mostly bound to proteins or other molecules rather than as free glutathione.
Limit: A tracer shows where the atoms went, not that intact glutathione arrived.
Study details and access
Statuses of food-derived glutathione in intestine, blood, and liver of rat.
2018 · Selected original full-text sections reviewed.
Route context: By mouth, 50 mg per kilogram.
How fast does IV glutathione clear in rats?
Model: Rats given single IV doses across a range of sizes.
Finding: The measured half-life fell from about 52 to about 11 minutes as the dose rose.
Limit: Rat kinetics cannot set a human schedule.
Study details and access
Pharmacokinetics of intravenously administered glutathione in the rat.
1986 · Original abstract reviewed.
Route context: IV, single doses.
Where does IV glutathione go?
Model: Rats given glutathione labelled with a radioactive tracer into a vein.
Finding: The tracer collected first in the kidneys, where glutathione is broken down.
Limit: The tracer also follows breakdown products, so it does not show intact glutathione in tissue.
Study details and access
The fate of extracellular glutathione in the rat.
1978 · Original abstract reviewed.
Route context: IV.
Can glutathione cross into the brain?
Model: Rats injected with tagged glutathione into the neck artery, brain measured after 15 seconds.
Finding: Brain uptake behaved like a carrier-driven process, and early brain tracer was mostly glutathione.
Limit: Seconds-long tracer uptake is not sustained delivery or a treatment effect.
Study details and access
Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat.
1990 · Selected original full-text sections reviewed.
Route context: Into the carotid artery.
Skin pigment · 6 papers
How does glutathione block melanin in a test tube?
Model: A cell-free mix of the pigment enzyme tyrosinase and its starting chemical.
Finding: Glutathione stopped melanin forming at the tested concentration; adding more starting chemical restored it, adding more enzyme did not.
Limit: Test-tube chemistry does not show what reaches skin cells.
Study details and access
Inhibitory Mechanism of Melanin Synthesis by Glutathione.
2008 · Selected original full-text sections reviewed.
Route context: Added directly to the reaction.
Does glutathione always slow pigment chemistry?
Model: Pigment-enzyme reactions tested across concentrations.
Finding: Glutathione speeded one step at low concentrations and slowed it at higher ones.
Limit: Concentration effects in a test tube; no body dose can be inferred.
Study details and access
The role of sulfhydryl compounds in mammalian melanogenesis: the effect of cysteine and glutathione upon tyrosinase and the intermediates of the pathway.
1988 · Original abstract reviewed.
Route context: Added directly to the reaction.
What happens in pigment cells?
Model: Mouse melanoma pigment cells whose melanin production was paused and restarted.
Finding: Glutathione interrupted the start of melanin production and moved the pigment enzyme away from where pigment forms.
Limit: A tumour cell line and a culture concentration, not skin in a person.
Study details and access
Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione.
1989 · Original abstract reviewed.
Route context: Added to the culture medium.
Does glutathione itself lighten pigment cells?
Model: Two mouse pigment-cell lines treated with glutathione or a modified ester form.
Finding: The ester form reduced melanin, but glutathione itself did not.
Limit: The ester is a different molecule; culture conditions are not a human dose.
Study details and access
The Glutathione Derivative, GSH Monoethyl Ester, May Effectively Whiten Skin but GSH Does Not.
2016 · Selected original full-text sections reviewed.
Route context: Added to the culture medium.
Does it change tanning in mice?
Model: Female mice given glutathione by mouth for 14 days, with UV-B exposure on three days.
Finding: Melanin and pigment-enzyme measures were lower than in UV-exposed mice without glutathione.
Limit: A mouse UV model; it cannot support IV or cosmetic claims in people.
Study details and access
Oral supplementation of L-glutathione prevents ultraviolet B-induced melanogenesis and oxidative stress in BALB/c mice.
2019 · Original abstract reviewed.
Route context: By mouth, 100 mg per kilogram daily.
What about injections in animals?
Model: Guinea pigs with UV-darkened skin given glutathione into the abdomen three times a week for three weeks.
Finding: Skin lightened more at higher doses, with fewer pigment granules, and short-term blood and organ checks showed no toxicity.
Limit: An animal model and a route people do not use; group sizes were not available.
Study details and access
Safety and efficacy of parenteral glutathione as a promising skin lightening agent: A controlled assessor blinded pharmacohistologic and ultrastructural study in an animal model.
2020 · Original abstract reviewed.
Route context: Into the abdomen, 10, 20 or 40 mg per kilogram.
Toxins, metals and the liver · 4 papers
Does glutathione protect the liver from paracetamol overdose?
Model: Fasted mice given a toxic dose of acetaminophen (paracetamol), then IV glutathione or NAC.
Finding: At the same molar dose, glutathione reduced liver injury by 82% and NAC by 46%, and glutathione restored the cells' energy supply better.
Limit: An acute mouse overdose model; NAC's effect grew at higher doses, and NAC is the approved human antidote.
Study details and access
Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine.
2010 · Original abstract reviewed.
Route context: IV, once after the overdose.
Does glutathione clear arsenic?
Model: Mice drinking arsenic-laced water, with or without glutathione injections.
Finding: Glutathione changed how arsenic was processed, and total arsenic in blood was higher than with arsenic alone.
Limit: A mouse model; moving arsenic between forms and organs is not the same as removing it.
Study details and access
[Effect of glutathione and sodium selenite on the metabolism of arsenic in mice exposed to arsenic through drinking water].
2008 · Original abstract reviewed.
Route context: Into the abdomen, 600 mg per kilogram.
Does it change arsenic in the brain?
Model: Mice drinking arsenic-laced water, given one of three glutathione doses.
Finding: The authors reported less inorganic arsenic in blood and less total arsenic in blood and brain.
Limit: The abstract gives no numbers, group sizes or injection frequency.
Study details and access
Effects of exogenous glutathione on arsenic burden and NO metabolism in brain of mice exposed to arsenite through drinking water.
2011 · Original abstract reviewed.
Route context: Into the abdomen, 200, 400 or 800 mg per kilogram.
What happens with mercury?
Model: Rats given methylmercury premixed with glutathione into a vein, plus isolated cells.
Finding: Glutathione moved more mercury into the kidneys, less into liver and blood, and more into bile.
Limit: A premixed metal compound in a vein differs from a supplement; more kidney mercury is not a safety benefit.
Study details and access
Organ distribution and cellular uptake of methyl mercury in the rat as influenced by the intra- and extracellular glutathione concentration.
1982 · Original abstract reviewed.
Route context: IV, premixed with methylmercury.
Cancer and chemotherapy · 7 papers
Does glutathione protect the kidneys during cisplatin without weakening it?
Model: Rats and mice, including tumour-bearing animals, given cisplatin with or without glutathione.
Finding: Kidneys were protected, with no measured loss of cisplatin's anti-tumour effect in the models tested.
Limit: Model-specific; a negative result in one tumour does not rule out interactions in others.
Study details and access
Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug.
1989 · Original abstract reviewed.
Route context: Glutathione by injection with cisplatin.
Did any animal study find bigger tumours?
Model: Animals with and without tumours given glutathione before or after cisplatin.
Finding: In animals without tumours, survival after a toxic cisplatin dose improved (90% versus 35%), but tumour-bearing animals had slightly larger tumours with glutathione.
Limit: The route and species details were unclear; not a human effect estimate.
Study details and access
Modulation of Cisplatin toxicity by glutathione.
1995 · Original abstract reviewed.
Route context: 500 mg per kilogram by injection.
Did survival change in tumour-bearing mice?
Model: Mice with lymphoma given cisplatin with or without glutathione.
Finding: 60-day survival was 55% with glutathione and 73% without, a difference the authors called not significant.
Limit: Possibly too small to detect a real difference; full text unavailable.
Study details and access
Glutathione administration against cisplatin-induced nephrotoxicity does not modify its cytotoxic activity.
1997 · Original abstract reviewed.
Route context: Glutathione by injection before cisplatin.
Does timing matter?
Model: Rats with kidney injury and two tumour models given cisplatin with sulfur-containing protectors, including glutathione.
Finding: Glutathione protected the kidneys best of those tested, but giving the protectors into a vein at the same time as cisplatin reduced its effect on one tumour.
Limit: The abstract omits doses and timing detail; the finding applies to the class tested.
Study details and access
Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity.
1991 · Original abstract reviewed.
Route context: IV, with cisplatin.
What about giving it before or after cisplatin?
Model: Mice with cisplatin kidney injury given IV glutathione before or after, plus three human-derived cancer cell lines.
Finding: Kidney injury improved in every glutathione group, and cisplatin still slowed the cancer cells in a dish.
Limit: Tumour effects were tested only in cells, not in tumour-bearing mice.
Study details and access
Evaluation of the effect of glutathione on cisplatin antitumor activity and kidney injury at different administration times.
2012 · Selected original full-text sections reviewed.
Route context: IV, 1,200 mg per kilogram per injection.
Can cancer cells use outside glutathione?
Model: Human-derived cervical cancer cells engineered to make more GGT, grown with little cysteine.
Finding: Added glutathione raised the cells' own glutathione and made them more resistant to cisplatin, only when GGT was high.
Limit: Engineered cells in a dish; not evidence about a person's supplement.
Study details and access
Enhanced resistance of HeLa cells to cisplatin by overexpression of gamma-glutamyltransferase.
2002 · Original abstract reviewed.
Route context: Added to the culture medium.
Does added glutathione change cisplatin's effect on lung cancer cells?
Model: A human-derived lung cancer cell line treated with cisplatin, with or without added glutathione.
Finding: Cisplatin slowed growth by about 53% alone but about 28% with glutathione, and cell death fell by half.
Limit: One cell line and culture concentrations; the paper has published corrections to details.
Study details and access
Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.
2018 · Selected original full-text sections reviewed.
Route context: Added to the culture medium.
Lungs and breathing · 2 papers
Does inhaled glutathione reach the lung lining better than IV?
Model: Sheep given 600 mg into a vein or as an inhaled mist.
Finding: IV raised lung-lining levels only briefly; the mist raised them about sevenfold at 30 minutes, back near baseline by two hours, without raising blood levels.
Limit: Healthy sheep and a short observation; no breathing outcome.
Study details and access
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol.
1990 · Original abstract reviewed.
Route context: IV or inhaled, 600 mg.
Why might a glutathione mist narrow the airways?
Model: Isolated guinea-pig lungs exposed to sulfur dioxide gas.
Finding: Sulfur dioxide narrowed the airways and sulfite formed; the authors of the human asthma study proposed sulfite from the glutathione solution as a cause.
Limit: This study did not test glutathione, so it cannot confirm that explanation.
Study details and access
Sulfur dioxide-induced bronchoconstriction in the isolated perfused and ventilated guinea-pig lung.
1992 · Original abstract reviewed.
Route context: Sulfur dioxide gas into isolated lungs.
How this guide was researched
This guide is built from a thorough review of the sources cited throughout it: published scientific studies, official medicine labels, registered clinical-trial plans, regulatory documents and published protocol descriptions. We also reviewed public online forums and community education groups where people describe their own experiences with glutathione.
The guide cites 191 sources, including 84 original scientific papers. Each type of source answers a different question. Studies show what researchers measured. Labels and protocol descriptions show how glutathione is used. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labeled by source type.
How this guide was made
Research and drafting were AI-assisted. Every cited source was checked against the original, and the guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.
This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.
Explore the sources
These are the documents cited in this guide. Studies, labels, website advice and personal accounts answer different questions. A source being listed does not mean every statement on its page is endorsed.
Showing 191 sources
- 01
Pharmacy Compounding Advisory Committee: Glutathione evaluation ↗
Regulatory source
Official document reviewed.
- 02
- 03
タチオン注射用100mg/200mg (Tathion for Injection 100 mg and 200 mg): package insert ↗
Official label
Official package insert reviewed in Japanese.
- 04
TAD 600 mg/4 ml and TAD 2500 mg/25 ml: summary of product characteristics ↗
Official label
Copy of the official prescribing information reviewed; AIFA's own database page could not be read.
- 05
- 06
GLUTATHIONE DISULFIDE (UNII ULW86O013H): substance record ↗
Regulatory source
Official document reviewed.
- 07
タチオン錠50mg・100mg・散20% (Tathion Tablets and Powder): package insert ↗
Official label
Official package insert reviewed in Japanese.
- 08
FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables ↗
Regulatory source
Official document reviewed.
- 09
- 10
Bulk Drug Substances Nominated for Use in Compounding Under Section 503A ↗
Regulatory source
Official document reviewed.
- 11
GLUTATHIONE SODIUM: substance record ↗
Regulatory source
Indexed record text reviewed; the full page could not be opened.
- 12
S-Acetylglutathione: compound record ↗
Regulatory source
Indexed record text reviewed; the full page could not be opened.
- 13
- 14
- 15
Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. ↗
Human trial
Selected original full-text sections reviewed.
- 16
Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. ↗
Human trial
Original abstract reviewed.
- 17
Glutathione Protocol Guide - Dosing Context, Routes & Safety ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 18
Glutathione What the Evidence Supports by Route ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 19
Glutathion ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 20
Glutathione for Melasma and Dark Spots: Does It Really Work? ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 21
Glutathione Injection ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 22
Glutathione Injections for Antioxidant, Liver, and Immune Support ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 23
Glutathione Dosage Guide: Protocols & Research ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 24
Glutathione ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 25
Glutathione Therapy, Online Telehealth ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 26
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. ↗
Human trial
Original abstract reviewed.
- 27
Efficacy of intravenous glutathione vs. placebo for skin tone lightening ↗
Human report
Selected original full-text sections reviewed.
- 28
Glutathione (600 mg Vial) Dosage Protocol ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 29
Glutathione dosing schedule ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 30
Glutathione Dosing Calculator ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 31
Comprar Glutatión Reducido (GSH) España ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 32
- 33
FDA reminds compounders not to use dietary supplement grade glutathione for injectables ↗
Regulatory source
Official document reviewed.
- 34
Adverse Events Linked to Injectable Glutathione Compounded with Dietary Supplement Grade Ingredient: Current Situation ↗
Regulatory source
Official document reviewed.
- 35
Nebulized glutathione induces bronchoconstriction in patients with mild asthma. ↗
Human trial
Original abstract reviewed.
- 36
Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. ↗
Human trial
Original abstract reviewed.
- 37
Glutathione Injection Dosing Protocol: 600 mg Vial — Antioxidant & Detox Guide ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 38
Glutathione Uses, Benefits & Dosage ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 39
S-Acetyl L-Glutathione ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 40
กลูตาไธโอน: Check-Sure-Share consumer fact check on glutathione (in Thai) ↗
Regulatory source
Official document reviewed.
- 41
Glutathione as a skin whitening agent: Facts, myths, evidence and controversies ↗
Review
Original abstract reviewed.
- 42
The clinical effect of glutathione on skin color and other related skin conditions: A systematic review. ↗
Review
Original abstract reviewed.
- 43
Glutathione for skin lightening: a regnant myth or evidence-based verity? ↗
Review
Original abstract reviewed.
- 44
Glutathione and its antiaging and antimelanogenic effects. ↗
Human trial
Selected original full-text sections reviewed.
- 45
- 46
Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women. ↗
Human trial
Selected original full-text sections reviewed.
- 47
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. ↗
Human report
Selected original full-text sections reviewed.
- 48
Effects of reduced glutathione therapy on chronic hepatitis B. ↗
Human trial
Selected original full-text sections reviewed.
- 49
Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients. ↗
Human trial
Selected full-text sections reviewed (indexed or verification-assistant copy).
- 50
Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study. ↗
Human trial
Selected original full-text sections reviewed.
- 51
Glutathione supplementation suppresses muscle fatigue induced by prolonged exercise via improved aerobic metabolism. ↗
Human trial
Selected original full-text sections reviewed.
- 52
Reduced intravenous glutathione in the treatment of early Parkinson's disease. ↗
Human report
Original abstract reviewed.
- 53
Phase IIb Study of Intranasal Glutathione in Parkinson's Disease. ↗
Human trial
Original abstract reviewed.
- 54
- 55
- 56
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update ↗
Guideline
Selected original full-text sections reviewed.
- 57
Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial. ↗
Human trial
Original abstract reviewed.
- 58
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis. ↗
Human trial
Original abstract reviewed.
- 59
Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. ↗
Human trial
Original abstract reviewed.
- 60
Randomized Clinical Trial of How Long-Term Glutathione Supplementation Offers Protection from Oxidative Damage and Improves HbA1c in Elderly Type 2 Diabetic Patients. ↗
Human trial
Selected original full-text sections reviewed.
- 61
- 62
Anemia and chronic renal failure: a therapeutical approach by reduced glutathione parenteral administration. ↗
Human trial
Original abstract reviewed.
- 63
Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases. ↗
Human report
Selected original full-text sections reviewed.
- 64
Glutathione IV Therapy Miami ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 65
Glutathione IV Drip or Push in London ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 66
High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. ↗
Human report
Original abstract reviewed.
- 67
Glutathione Peptide Injection: How to Use, Reconstitute, and Dose ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 68
Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. ↗
Human report
Selected original full-text sections reviewed.
- 69
Codeage Liposomal Glutathione Supplement, 500 mg Setria L-Glutathione Capsules ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 70
Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study. ↗
Human trial
Selected original full-text sections reviewed.
- 71
S-Acetyl Glutathione Synergy ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 72
Inhaled Glutathione for COPD ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 73
Glutathione Push & IV ↗
Dosing website
Selected page sections reviewed; protocol-source claim, not a tested dose.
- 74
Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems ↗
Registered study
Registry record reviewed.
- 75
Sublingual L-GSH Supplementation in Male Subjects With Smoking Habit and/or Hypertension ↗
Registered study
Registry record reviewed.
- 76
Glutathione (GSH) In The Treatment of Parkinson's Disease ↗
Registered study
Registry record reviewed.
- 77
- 78
Glutathione IV - can someone share experiences? How long is it supposed to last? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 79
Have anyone tried glutathione iv? How was the experience? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 80
Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients. ↗
Human report
Original abstract reviewed.
- 81
- 82
Increase in the protein-bound form of glutathione in human blood after the oral administration of glutathione. ↗
Human report
Original abstract reviewed.
- 83
Bioavailability of dietary glutathione: effect on plasma concentration. ↗
Cell / animal research
Original abstract reviewed.
- 84
Statuses of food-derived glutathione in intestine, blood, and liver of rat. ↗
Cell / animal research
Selected original full-text sections reviewed.
- 85
Pharmacokinetics of glutathione and its metabolites in normal subjects. ↗
Human report
Original abstract reviewed.
- 86
Liposomal glutathione outperforms plain glutathione in uptake, cell regeneration and systemic availability: evidence from cellular and human models. ↗
Human report
Selected original full-text sections reviewed.
- 87
A Targeted Metabolomic Assessment of Oral Glutathione Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial. ↗
Human trial
Selected original full-text sections reviewed.
- 88
Oral Administration of S-acetyl-glutathione: Impact on the Levels of Glutathione in Plasma and in Erythrocytes of Healthy Volunteers ↗
Human trial
Selected original full-text sections reviewed.
- 89
Safety of S-acetyl glutathione as an novel food pursuant to Regulation (EU) 2015/2283 ↗
Regulatory source
Official document reviewed.
- 90
Central nervous system uptake of intranasal glutathione in Parkinson's disease. ↗
Human report
Selected original full-text sections reviewed.
- 91
Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. ↗
Human report
Original abstract reviewed.
- 92
Has anyone here tried Glutathione injections? Did it work? How was your experience? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 93
Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases ↗
Laboratory study
Selected original full-text sections reviewed.
- 94
Extended storage of reduced glutathione solutions ↗
Patent
Selected original full-text sections reviewed.
- 95
Anaerobic Decomposition of Glutathione in Aqueous Solution ↗
Laboratory study
Selected original full-text sections reviewed.
- 96
- 97
- 98
Therapure My Liposomal Glutathione Stability Statement ↗
Product information
Product page reviewed; manufacturer or seller statement, not independent testing.
- 99
Glutathione Reconstitution — Safe Mixing & Storage Guide ↗
Product information
Product page reviewed; manufacturer or seller statement, not independent testing.
- 100
Glutathione IV Solution ↗
Product information
Product page reviewed; manufacturer or seller statement, not independent testing.
- 101
Oral reduced L-glutathione improves growth in pediatric cystic fibrosis patients. ↗
Human trial
Original abstract reviewed.
- 102
Oral Glutathione and Growth in Cystic Fibrosis: A Multicenter, Randomized, Placebo-controlled, Double-blind Trial. ↗
Human trial
Selected original full-text sections reviewed.
- 103
- 104
A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease. ↗
Human trial
Original abstract reviewed.
- 105
Effect of inhaled glutathione on airway response to 'Fog' challenge in asthmatic patients. ↗
Human trial
Original abstract reviewed.
- 106
Interventions for preventing neuropathy caused by cisplatin and related compounds. ↗
Review
Original abstract reviewed.
- 107
Potential use of glutathione as a treatment for Parkinson's disease ↗
Review
Original abstract reviewed.
- 108
The fate of extracellular glutathione in the rat. ↗
Cell / animal research
Original abstract reviewed.
- 109
[Effect of glutathione and sodium selenite on the metabolism of arsenic in mice exposed to arsenic through drinking water]. ↗
Cell / animal research
Original abstract reviewed.
- 110
Effects of exogenous glutathione on arsenic burden and NO metabolism in brain of mice exposed to arsenite through drinking water. ↗
Cell / animal research
Original abstract reviewed.
- 111
Organ distribution and cellular uptake of methyl mercury in the rat as influenced by the intra- and extracellular glutathione concentration. ↗
Cell / animal research
Original abstract reviewed.
- 112
Inhibitory Mechanism of Melanin Synthesis by Glutathione ↗
Cell / animal research
Selected original full-text sections reviewed.
- 113
The role of sulfhydryl compounds in mammalian melanogenesis: the effect of cysteine and glutathione upon tyrosinase and the intermediates of the pathway. ↗
Cell / animal research
Original abstract reviewed.
- 114
Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione. ↗
Cell / animal research
Original abstract reviewed.
- 115
The Glutathione Derivative, GSH Monoethyl Ester, May Effectively Whiten Skin but GSH Does Not. ↗
Cell / animal research
Selected original full-text sections reviewed.
- 116
Oral supplementation of L-glutathione prevents ultraviolet B-induced melanogenesis and oxidative stress in BALB/c mice. ↗
Cell / animal research
Original abstract reviewed.
- 117
Safety and efficacy of parenteral glutathione as a promising skin lightening agent: A controlled assessor blinded pharmacohistologic and ultrastructural study in an animal model. ↗
Cell / animal research
Original abstract reviewed.
- 118
Glutathione Whitening Pills Induced Toxic Epidermal Necrolysis: An Unusual Case Confirmed by Enzyme-Linked Immunospot Assay and Liquid Chromatography-Mass Spectrometry. ↗
Human report
Bibliographic record only; no abstract available.
- 119
Revision of instructions for glutathione for injection and related products ↗
Regulatory source
Readable republication of the official notice reviewed; the official PDF is image-only.
- 120
Literature Analysis of Anaphylactic Shock Induced by Reduced Glutathione for Injection ↗
Human report (case collection)
Selected original full-text sections reviewed.
- 121
FDA Pharmacy Compounding Advisory Committee safety presentation on glutathione ↗
Regulatory source
Official document reviewed.
- 122
A case of glutathione-induced life-threatening asthma attack ↗
Human report
Selected original full-text sections reviewed.
- 123
Type I Kounis syndrome in a young woman without chest pain: a case report ↗
Human report
Selected full-text sections reviewed (indexed or verification-assistant copy).
- 124
Systemic Inflammatory Response Syndrome Following High-Dose Intravenous Glutathione-Containing Revitalising Solution in a Patient on Tirzepatide: A Case Report. ↗
Human report
Selected original full-text sections reviewed.
- 125
Intravenous Glutathione and Vitamin Supplementation Causing Stevens-Johnson Syndrome: A Case Report. ↗
Human report
Original abstract reviewed.
- 126
Glutathione sickness? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 127
Does anyone have problems with Glutathione supplementation? I think it makes me worse! ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 128
Seven cases of probable endotoxin poisoning related to contaminated glutathione infusions. ↗
Human report
Selected original full-text sections reviewed.
- 129
Unauthorized injectables and other health products from Galena Pharm Inc. pharmacy may pose serious health risks ↗
Regulatory source
Official document reviewed.
- 130
Victory Medical Center Pharmacy issues voluntary nationwide recall of certain lots of compounded glutathione ↗
Regulatory source
Official document reviewed.
- 131
Centric Compounding recall of glutathione, Myers Cocktail, and Tri-Immune Boost ↗
Regulatory source
Official document reviewed.
- 132
Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels ↗
Regulatory source
Official document reviewed.
- 133
FDA Pharmacy Compounding Advisory Committee meeting, June 8, 2022: transcript ↗
Regulatory source
Official document reviewed.
- 134
- 135
- 136
Drug Product Database: search for the active ingredient glutathione ↗
Regulatory source
Search results checked by a verification assistant: four records, none an authorized glutathione injection.
- 137
Skycare Compounding Laboratories products recall (no market authorization) ↗
Regulatory source
Official recall page reviewed; lists glutathione 200 mg/mL solution and glutathione IV drips sold without authorization.
- 138
- 139
Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026 (F2026L00707) ↗
Regulatory source
Glutathione entry (item 2379) reviewed: oral route only, adults only, pregnancy and breastfeeding warning.
- 140
Advertising guidance for businesses involved with intravenous (IV) vitamin and related therapies: Complying with therapeutic goods advertising requirements ↗
Regulatory source
Official document reviewed.
- 141
구치온주600밀리그램 (Guchion Injection 600 mg, reduced glutathione): product information ↗
Official product record
Official record reviewed (in Korean): prescription medicine; sodium bicarbonate listed as an additive.
- 142
- 143
- 144
- 145
- 146
- 147
Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. ↗
Cell / animal research
Original abstract reviewed.
- 148
- 149
Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells. ↗
Cell / animal research
Selected original full-text sections reviewed.
- 150
Enhanced resistance of HeLa cells to cisplatin by overexpression of gamma-glutamyltransferase. ↗
Cell / animal research
Original abstract reviewed.
- 151
Catabolism of extracellular glutathione supplies cysteine to support tumours ↗
Cell / animal research
Original abstract and selected figure legends reviewed.
Result detail: Tumours in mice broke down glutathione from their surroundings for cysteine; blocking GGT slowed tumour growth. Glutathione was added to cells in a dish, not given to animals or people.
- 152
Physical Compatibility of Reduced Glutathione for Injection With 44 Intravenous Drugs During Simulated Y-site Administration ↗
Laboratory study
Original abstract reviewed.
- 153
3 months Oral Glutathione Results ( Before & After ) ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 154
My 21 day oral glutathione results 🤞(Before & After) ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 155
Glutathione for hyperpigmentation black skin ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 156
[Compounds] Injectable Glutathione and Other Liver Support ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 157
[Blood Work] Effectiveness of Intramuscular Glutathione (follow up) ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 158
My experience with glutathione (oral and intramuscular) ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 159
In remission! GABA, glutathione, lymphatic drainage. ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 160
In remission! GABA, glutathione, and lymphatic drainage massage ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 161
I'd love to be very very pale, but my skin is tan. Any tips? I'm currently taking glutathione. ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 162
Injectable glutathione IM experiences? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 163
How bad is the burn with Glutathione? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 164
Anyone Else Experience Numbness for Days After SubQ Glutathione Injections? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 165
How are you guys dealing with pain at inj site? Glutathione ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 166
Glutathione: IM or SubQ ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 167
Glutathione complex formation with mercury(II) in aqueous solution at physiological pH ↗
Laboratory study
Methods section reviewed for the pH of unbuffered glutathione in water (pH 2.7–2.8).
- 168
Glutathione experiences? It seems to be wiping me out as a moderate - severe patient. To stop or continue? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 169
Reaction Following IV Vitamin C + Glutathione Therapy ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 170
Feeling Weird after IV Glutathione ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 171
Anyone get acne from taking glutathione orally? Did it eventually go away? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 172
Glutathione Injections ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 173
Negative reaction to glutathione? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 174
Reconstituting 600mg of Glutathione - HELP! ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 175
How many vials of glutathione do I need? ↗
Community account
Public thread reviewed; usernames and identifying details omitted.
- 176
ACETADOTE (acetylcysteine) injection: prescribing information ↗
Official label
Indication section reviewed (verification assistant).
- 177
Acetylcysteine solution, USP (inhalation and oral use): label ↗
Official label
Indications reviewed (verification assistant).
- 178
Policy Regarding N-acetyl-L-cysteine: Guidance for Industry ↗
Regulatory source
Official guidance page reviewed.
- 179
Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial ↗
Human report
Selected original full-text sections reviewed.
- 180
A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage ↗
Human trial
Original abstract reviewed. Most authors worked for Nestlé, which markets glycine and NAC products.
Result detail: 114 healthy older adults took one of three GlyNAC doses or placebo for 2 weeks; total glutathione and the reduced-to-oxidized ratio did not differ from placebo. A higher level appeared only in a post-hoc subgroup.
- 181
A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+ ↗
Human report
Original abstract reviewed; participant numbers, dose and safety statement checked in the full text by a verification assistant.
- 182
Effect of oral glutathione on hepatic glutathione levels in rats and mice ↗
Cell / animal research
Selected original full-text sections reviewed.
- 183
Oral glutathione increases tissue glutathione in vivo. ↗
Cell / animal research
Original abstract reviewed.
- 184
Pharmacokinetics of intravenously administered glutathione in the rat. ↗
Cell / animal research
Original abstract reviewed.
- 185
Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat. ↗
Cell / animal research
Selected original full-text sections reviewed.
- 186
Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. ↗
Cell / animal research
Original abstract reviewed.
- 187
Glutathione administration against cisplatin-induced nephrotoxicity does not modify its cytotoxic activity. ↗
Cell / animal research
Original abstract reviewed.
- 188
Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity. ↗
Cell / animal research
Original abstract reviewed.
- 189
Evaluation of the effect of glutathione on cisplatin antitumor activity and kidney injury at different administration times. ↗
Cell / animal research
Selected original full-text sections reviewed.
- 190
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. ↗
Cell / animal research
Original abstract reviewed.
- 191
Sulfur dioxide-induced bronchoconstriction in the isolated perfused and ventilated guinea-pig lung. ↗
Cell / animal research
Original abstract reviewed.
No matching sources
Try a different term or show the full list.
Updates and corrections
Updated September 27, 2026. We added a placebo-controlled trial in people with liver cirrhosis, in which 500 mg a day of swallowed glutathione for 12 weeks did not raise blood glutathione or improve antioxidant measures, to the liver section and the table of oral studies.
Corrected September 24, 2026. We corrected the summary image's description of the sport rule on IV drips, which hepatitis B study reported liver-stiffness results, the reasoning attributed to one IV study, a rat blood-level figure and an animal survival figure in the research library, the authors of one source, the count of original papers, two registry descriptions, how the skin reviews are summarized and one community account.
Updated September 23, 2026. This version replaces the earlier Doserly glutathione page. It adds the official Japanese and Italian label doses; separate oral, injection and IV schedule tables with their sources; sections on storage, stopping, monitoring, side effects, contaminated injections and legal status; a comparison with NAC, GlyNAC and NAD+; and community experiences. It corrects the earlier page's description of a 12-week skin trial, which tested a combination capsule rather than glutathione alone and found no clear difference from placebo. It also carries over the verified points from the earlier version. The date describes this revision, not a fresh check of every source.
Found an error or a relevant study we missed? Report a correction with the guide title, the specific passage and a supporting source if available. Please leave out personal health records. See our editorial policy for how we handle attribution, evidence limits and corrections.